TissGeneSummary for FAM71F1 |
Gene summary |
Basic gene information | Gene symbol | FAM71F1 |
Gene name | family with sequence similarity 71, member F1 | |
Synonyms | FAM137A|NYD-SP18 | |
Cytomap | UCSC genome browser: 7q32.1 | |
Type of gene | protein-coding | |
RefGenes | NM_001282788.1, NM_001282789.1,NM_032599.3,NR_104242.1,NR_104243.1, | |
Description | family with sequence similarity 137, member Aprotein FAM71F1testes development-related NYD-SP18testis development protein NYD-SP18 | |
Modification date | 20141207 | |
dbXrefs | HGNC : HGNC | |
Ensembl : ENSG00000135248 | ||
HPRD : 14861 | ||
Vega : OTTHUMG00000158276 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_FAM71F1 | |
BioGPS: 84691 | ||
Pathway | NCI Pathway Interaction Database: FAM71F1 | |
KEGG: FAM71F1 | ||
REACTOME: FAM71F1 | ||
Pathway Commons: FAM71F1 | ||
Context | iHOP: FAM71F1 | |
ligand binding site mutation search in PubMed: FAM71F1 | ||
UCL Cancer Institute: FAM71F1 | ||
Assigned class in TissGDB* | B | |
Included tissue-specific gene expression resources | HPA,TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Testis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCT | |
Reference showing the relevant tissue of FAM71F1 | ||
Description by TissGene annotations | TissgsKTS |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for FAM71F1 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
HNSC | -0.867920393 | -2.427238998 | 1.559318605 | 1.18E-05 | 6.64E-05 |
LUSC | -0.928593352 | -2.284952176 | 1.356358824 | 1.52E-06 | 3.72E-06 |
Top |
TissGene-miRNA for FAM71F1 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for FAM71F1 |
TissGeneSNV for FAM71F1 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.G127R | UCEC | 1 |
p.V108A | STAD | 1 |
p.R22I | UCEC | 1 |
p.A120D | STAD | 1 |
p.L70Q | HNSC | 1 |
p.L154F | COAD | 1 |
p.K9N | UCEC | 1 |
p.S241T | UCEC | 1 |
p.L336M | LUAD | 1 |
p.V76L | UCEC | 1 |
p.W132X | SKCM | 1 |
p.W132* | SKCM | 1 |
p.A50V | STAD | 1 |
p.T213M | HNSC | 1 |
p.P35T | SARC | 1 |
p.N282H | STAD | 1 |
p.H214Q | STAD | 1 |
p.E35* | BLCA | 1 |
p.E35K | BLCA | 1 |
p.A32D | LUAD | 1 |
p.A261V | KIRP | 1 |
p.A261V | UVM | 1 |
p.T205S | LUSC | 1 |
p.A261V | PAAD | 1 |
p.D262N | MESO | 1 |
p.P334Q | STAD | 1 |
p.L211V | BLCA | 1 |
p.L211V | HNSC | 1 |
p.P114S | SKCM | 1 |
p.G309E | SKCM | 1 |
p.S289F | SKCM | 1 |
p.P23L | HNSC | 1 |
p.S107W | BLCA | 1 |
p.L59F | SKCM | 1 |
p.S14* | BLCA | 1 |
p.V156A | KIRC | 1 |
p.R301C | GBM | 1 |
p.D299N | GBM | 1 |
p.E10K | SKCM | 1 |
p.L59F | UCEC | 1 |
p.A33T | STAD | 1 |
p.C296* | LUAD | 1 |
p.L319M | COAD | 1 |
p.T213M | STAD | 1 |
p.R301C | STAD | 1 |
p.R91I | UCEC | 1 |
p.S228L | COAD | 1 |
Top |
TissGeneCNV for FAM71F1 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for FAM71F1 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for FAM71F1 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for FAM71F1 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for FAM71F1 |
TissGeneDrug for FAM71F1 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for FAM71F1 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0028754 | Obesity | 1 | BeFree,GAD |